Educational Tools

GuidelineStat™
Managing Rectal Cancer in the Clinical Setting

GuidelineStat™ Managing Rectal Cancer in the Clinical Setting is a CME initiative developed in conjunction with a leading expert from Georgetown University that provides evidence-based guideline content for the treatment and management of rectal cancer.

This learning activity has been designated for a maximum of 1.50 AMA PRA Category 1 Credits™.

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

After reviewing this module, the participant will be better able to:
  • Identify challenges related to determining an optimal continuum of care for patients with advanced stage rectal cancer
  • Discuss current and emerging treatments for patients with stage III rectal cancer
  • Distinguish between treatment options for synchronous metastatic rectal cancer versus metasynchronous metastatic rectal cancer

View all Learning Objectives.

Content Highlights
Colorectal cancer (CRC) is the third most frequently diagnosed cancer in the United States and the second leading cause of cancer death behind lung cancer. The lifetime risk of being diagnosed with CRC is about 6%, although individuals who have 1 or more first-degree relatives with CRC are at higher risk.

Please register to learn more


Editorial Faculty
John L. Marshall, MD
Chief, Hematology and Oncology
Georgetown University
Associate Director
Clinical Research
Lombardi Comprehensive Cancer Center
Washington, DC
This educational activity was made possible through an unrestricted educational grant from:
Developed and published in 2009 by Mechanisms in Medicine Inc. Copyright © Mechanisms in Medicine Inc. and Imedex, LLC. All rights reserved.
About Us | Contact Us | Terms of Use | Privacy Policy | Technical Requirements | Site Map | Help